EUVIMEDEUVIMED entdecken
Korrektur

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption

Chan Kim, Hanseul Yang, Yoko Fukushima, Phei Er Saw, Junyeop Lee, Jin-Sung Park, Intae Park, Jinmyung Jung, Hiroshi Kataoka, Doheon Lee, Won Do Heo, Injune Kim und 5 weitere

Cancer Cell · 2026-08 · 44 (8) · 1705-1709

DOI: 10.1016/j.ccell.2026.06.014 ↗

Kurz gefasst

Korrektur in der Zeitschrift Cancer Cell, 2026-08. Verfasst von Chan Kim und 16 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kim, C., Yang, H., Fukushima, Y., Er Saw, P., Lee, J., Park, J. S., Park, I., Jung, J., Kataoka, H., Lee, D., Heo, W. D., Kim, I., Jon, S., Adams, R. H., Nishikawa, S. I., Uemura, A., & Koh, G. Y. (2026). Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption. Cancer Cell, 44(8), 1705-1709. https://doi.org/10.1016/j.ccell.2026.06.014

Vancouver

Kim C, Yang H, Fukushima Y, Er Saw P, Lee J, Park JS, et al. Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption. Cancer Cell. 2026;44(8):1705-1709. doi:10.1016/j.ccell.2026.06.014

BibTeX
@article{Kim2026,
  author = {Kim, Chan and Yang, Hanseul and Fukushima, Yoko and Er Saw, Phei and Lee, Junyeop and Park, Jin-Sung and Park, Intae and Jung, Jinmyung and Kataoka, Hiroshi and Lee, Doheon and Heo, Won Do and Kim, Injune and Jon, Sangyong and Adams, Ralf H and Nishikawa, Shin-Ichi and Uemura, Akiyoshi and Koh, Gou Young},
  title = {Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {8},
  pages = {1705--1709},
  doi = {10.1016/j.ccell.2026.06.014}
}
Kostenlos starten →